Maximilian Jara

Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial

Rohit Loomba, Manal F. Abdelmalek, Matthew J. Armstrong et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 413 citations · Full text

Placebo-controlled Phase 2, Hepatology, Liver Physiology +6

Recipient and Donor Body Mass Index as Important Risk Factors for Delayed Kidney Graft Function

Annemarie Weißenbacher, Maximilian Jara, Hanno Ulmer et al. · Transplantation · 2012 · 97 citations

Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study

Quentin M. Anstee, Tina Landsvig Berentzen, Louise Maymann Nitze et al. · The Lancet Regional Health - Europe · 2023 · 94 citations · Full text

Accidentally Ingested Toothpicks Causing Severe Gastrointestinal Injury: A Practical Guideline for Diagnosis and Therapy Based on 136 Case Reports

Cathérine L. Steinbach, Martin Stockmann, Maximilian Jara et al. · World Journal of Surgery · 2013 · 89 citations

Reductions in post‐hepatectomy liver failure and related mortality after implementation of the LiMAx algorithm in preoperative work‐up: a single‐centre analysis of 1170 hepatectomies of one or more segments

Maximilian Jara, Tim Reese, Maciej Malinowski et al. · HPB · 2015 · 81 citations · Full text

Limax Algorithm, Hepatology, Medicine +10